Chief Scientific Officer (Consulting)
Galit Alter received her PhD in experimental medicine from McGill University, and is currently a Professor in Medicine at Harvard Medical School and a faculty member at the Ragon Institute of MGH, MIT, and Harvard. Her research interests lie at the intersection of the innate immune response and the adaptive humoral immune response, with a focus on defining the role of innate immune recruiting antibodies in providing specificity to the innate immune system to kill virally infected cells. In this capacity, Dr. Alter has developed a suite of antibody profiling assays, collectively Systems Serology, that aim at gaining a deeper appreciation of the correlates of humoral immune activity against HIV and beyond. Galit serves as SeromYx CSO on a part-time consulting basis.